Guardant Health, Inc. (GH) - Comprehensive Stock Analysis & Investment Research
Deep dive into Guardant Health, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Guardant Health, Inc. Investment Summary
When evaluating whether Guardant Health, Inc. (GH) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Guardant Health, Inc. (GH) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry. The company employs approximately 2,284 people. With a market capitalization of $12 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Guardant Health, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Guardant Health, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Guardant Health, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Guardant Health, Inc. (Stock Symbol: GH) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Medical Laboratories industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Guardant Health, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Guardant Health, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Guardant Health, Inc....
Revenue & Growth Analysis
Guardant Health, Inc. generates annual revenues of $982 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Guardant Health, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Guardant Health, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Guardant Health, Inc....
Strategic Market Position
Guardant Health, Inc. strategically competes in the highly dynamic Services-Medical Laboratories marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Guardant Health, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-309 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a -7.5% gross margin characteristic of commodity-like businesses or high-volume, low-margin operators. Thin gross margins require exceptional operational efficiency and volume to generate meaningful profits. Companies at this margin level are particularly sensitive to cost increases or pricing pressures.
Operating margin of -74.4% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.17x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 4.87 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.